TIL - Financial Reports List - Instil Bio, Inc. - IntrinsicAlpha

Instil Bio, Inc. TIL

Healthcare - Biotechnology - NASDAQ - US

$ 16.0

3.53 %

$ 105 M

Market Cap

-1.4

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	7.97%	8.06%
Annual Report	FY	10-K	2024-12-31	0.00%	52.50%	18.78%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	65.86%	64.58%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	20.07%	35.07%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	56.85%	66.33%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	76.00%	77.37%
Annual Report	FY	10-K	2023-12-31	0.00%	30.06%	60.02%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-19.93%	-17.77%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	68.37%	64.26%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-4.08%	-7.66%

1